CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 138 filers reported holding CLOVIS ONCOLOGY INC in Q1 2014. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $207,000 | -62.0% | 5,925 | 0.0% | 0.00% | -60.0% |
| Q3 2015 | $545,000 | +4.6% | 5,925 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $521,000 | +18.4% | 5,925 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $440,000 | -20.0% | 5,925 | -39.7% | 0.01% | -11.1% |
| Q4 2014 | $550,000 | +13.9% | 9,825 | -7.7% | 0.01% | +12.5% |
| Q3 2014 | $483,000 | -27.4% | 10,650 | -33.6% | 0.01% | -27.3% |
| Q2 2014 | $665,000 | -40.2% | 16,050 | 0.0% | 0.01% | -45.0% |
| Q1 2014 | $1,112,000 | – | 16,050 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $18,097,419,000 | 17.62% |
| Boxer Capital, LLC | 850,000 | $37,757,000 | 14.60% |
| Consonance Capital Management LP | 2,730,887 | $121,306,000 | 13.32% |
| Palo Alto Investors LP | 3,804,088 | $168,978,000 | 9.64% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 298,982 | $13,281,000 | 8.01% |
| Redmile Group, LLC | 1,620,355 | $71,976,000 | 6.20% |
| Crosspoint Capital Strategies, LLC | 84,076 | $3,735,000 | 3.32% |
| Ghost Tree Capital, LLC | 220,000 | $9,772,000 | 2.35% |
| PointState Capital LP | 3,171,978 | $140,899,000 | 2.03% |
| NEA Management Company, LLC | 1,139,890 | $50,634,000 | 2.01% |